{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T16:14:21Z","timestamp":1760890461080},"reference-count":0,"publisher":"Harborside Press, LLC","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JADPRO"],"published-print":{"date-parts":[[2022,4,1]]},"abstract":"<jats:p>Multiple myeloma remains the second most common hematologic malignancy, and relapse rates are high, with refractory disease common with each relapse. Chimeric antigen receptor (CAR)\u2013modified T cells are a promising new treatment, and at JADPRO Live Virtual 2021, presenters compared pivotal trials in CAR T-cell therapy for multiple myeloma, discussed how to recognize and manage common toxicities after CAR T-cell infusion, and reviewed pre-CAR-T consultation and post-CAR-T management.<\/jats:p>","DOI":"10.6004\/jadpro.2022.13.3.30","type":"journal-article","created":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T21:25:36Z","timestamp":1651699536000},"page":"328-332","source":"Crossref","is-referenced-by-count":1,"title":["New Frontiers: The Role of CAR T-Cell Therapy in Multiple Myeloma"],"prefix":"10.6004","volume":"13","author":[{"given":"Alli","family":"McClanahan, APRN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Spychalla, PA-C","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4047","published-online":{"date-parts":[[2022,4,1]]},"container-title":["Journal of the Advanced Practitioner in Oncology"],"original-title":[],"deposited":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T21:26:18Z","timestamp":1651699578000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.advancedpractitioner.com\/issues\/volume-13,-number-3-(apr-2022)\/new-frontiers-the-role-of-car-t-cell-therapy-in-multiple-myeloma.aspx"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,1]]},"references-count":0,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,4,1]]},"published-print":{"date-parts":[[2022,4,1]]}},"URL":"https:\/\/doi.org\/10.6004\/jadpro.2022.13.3.30","relation":{},"ISSN":["2150-0878"],"issn-type":[{"value":"2150-0878","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,1]]}}}